Comparison of Integrated Neuromuscular Inhibition Technique (INIT) and Active Release Technique (ART) in Patients With Upper Trapezius Trigger Points

Starting soon · Not applicable

Conditions studied: Myofascial Pain Syndrome

In brief

The goal of this clinical trial is to determine whether two manual therapy techniques-Integrated Neuromuscular Inhibition Technique (INIT) and Active Release Technique (ART)-can reduce pain, improve neck range of motion, and decrease functional disability in adults with upper trapezius myofascial trigger points. The main questions it aims to answer are: Does INIT reduce pain, improve ROM, and reduce functional disability more effectively than ART? Does ART provide similar or different treatment benefits compared to INIT? Researchers will compare INIT with ART to see which technique produces greater improvements in pain, ROM, and functional disability. Participants will: Receive treatment sessions of either INIT or ART. Undergo assessment of pain, cervical range of motion, and functional disability before and after the intervention.

Key facts

Study ID: NCT07395154
Run by: Lahore University of Biological and Applied Sciences
People needed: 64
Starts: 2026-02-15
Expected to finish: 2026-06-30
Last updated by the study team: 2026-02-09

Who can join

Age: 20 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Presence of active trigger points in the upper trapezius muscle.
Forward Head Posture (measured by craniovertebral angle).
Pain duration less than 3 months.

You may not qualify if…

History of trauma or surgery involving the cervical spine or shoulder
Neurological disorders (e.g., cervical radiculopathy)
Systemic conditions like diabetes or rheumatoid arthritis
Use of corticosteroids
Fibromyalgia, Thoracic Outlet Syndrome, Temporomandibular Joint Disorders

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.